Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection

(2016) Xu Zhang et al.   ANTIVIRAL RESEARCH

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

(2016) D. Corti et al.   SCIENCE

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

(2016) Z. A. Bornholdt et al.   SCIENCE

A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice

(2016) Shuya Zhou et al.   VACCINE

Pseudoparticle Neutralization Assay for Detecting Ebola- Neutralizing Antibodies in Biosafety Level 2 Settings

(2015) A. W. H. Chin et al.   CLINICAL CHEMISTRY

Development of therapeutics for treatment of Ebola virus infection

(2015) Haoyang Li et al.   MICROBES AND INFECTION

Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox

(2015) Qiang Liu et al.   Scientific Reports

Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro

(2014) Rong Zhu et al.   ARCHIVES OF VIROLOGY

Treatment of Ebola virus disease

(2014) Yazdan Yazdanpanah et al.   INTENSIVE CARE MEDICINE

What is Ebola?

(2014) R. A. Stein   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Less Is More: Ebola Virus Surface Glycoprotein Expression Levels Regulate Virus Production and Infectivity

(2014) Gopi S. Mohan et al.   JOURNAL OF VIROLOGY

Emergence of Zaire Ebola Virus Disease in Guinea

(2014) Sylvain Baize et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Care of Two Patients with Ebola Virus Disease in the United States

(2014) G. Marshall Lyon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus

(2014) Jonathan Audet et al.   Scientific Reports

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability

(2014) Beatriz Escudero-Pérez et al.   PLoS Pathogens

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae

(2013) Jens H. Kuhn et al.   ARCHIVES OF VIROLOGY

A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization

(2013) Wenbo Wang et al.   Retrovirology

A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China

(2012) Qiang Liu et al.   PLoS One

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

(2012) G. G. Olinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates

(2012) G. Wong et al.   Science Translational Medicine

Mouse Models for Filovirus Infections

(2012) Steven B. Bradfute et al.   Viruses-Basel

The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo

(2012) Allison Groseth et al.   PLoS Pathogens

Lethality and pathogenesis of airborne infection with filoviruses in A129  /  -/- interferon receptor-deficient mice

(2011) M. S. Lever et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Ebolavirusglycoprotein structure and mechanism of entry

(2009) Jeffrey E Lee et al.   Future Virology

Application of Bioluminescence Imaging to the Prediction of Lethality in Vaccinia Virus-Infected Mice

(2009) M. Zaitseva et al.   JOURNAL OF VIROLOGY

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses

(2009) Xiangguo Qiu et al.   PLoS One